A Day Up For Avenue Therapeutics, Inc.
Fri, Sep 30, 2022 at 07:42 PM
Avenue Therapeutics, Inc. (ATXI:NASDAQ) soared at $10.08, a gain of 39%. On Fri, Sep 30, 2022, ATXI:NASDAQ hit a New 2-Week High of $10.08. The stock got featured on our News Catalysts scanner on Fri, Sep 23, 2022 at 12:13 PM in the 'SPLIT' category. From Fri, Sep 16, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About Avenue Therapeutics, Inc. (ATXI:NASDAQ)
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.
Top 10 Gainers:
- SAI.TECH Global Corp Cl A Ord (SAI:NASDAQ), 43.36%
- F45 Training Holdings Inc. (FXLV:NYSE), 41.1%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 39.03%
- Alset EHome International Inc. (AEI:NASDAQ), 30.85%
- O2Micro International Limited (OIIM:NASDAQ), 30.15%
- PolarityTE, Inc. (PTE:NASDAQ), 27.94%
- Pulse Biosciences, Inc. (PLSE:NASDAQ), 27.78%
- VectivBio Holding AG (VECT:NASDAQ), 26.05%
- Vincerx Pharma Inc. (VINC:NASDAQ), 25.45%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 23.85%